Cargando…
Suprachoroidal Delivery of Small Molecules, Nanoparticles, Gene and Cell Therapies for Ocular Diseases
Suprachoroidal drug delivery technology has advanced rapidly and emerged as a promising administration route for a variety of therapeutic candidates, in order to target multiple ocular diseases, ranging from neovascular age-related macular degeneration to choroidal melanoma. This review summarizes t...
Autores principales: | Wan, Chen-rei, Muya, Leroy, Kansara, Viral, Ciulla, Thomas A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7926337/ https://www.ncbi.nlm.nih.gov/pubmed/33671815 http://dx.doi.org/10.3390/pharmaceutics13020288 |
Ejemplares similares
-
Suprachoroidal Delivery of Viral and Nonviral Gene Therapy for Retinal Diseases
por: Kansara, Viral, et al.
Publicado: (2020) -
Evaluation of Long-Lasting Potential of Suprachoroidal Axitinib Suspension Via Ocular and Systemic Disposition in Rabbits
por: Kansara, Viral S., et al.
Publicado: (2021) -
Suprachoroidal Injection of Triamcinolone Acetonide Suspension: Ocular Pharmacokinetics and Distribution in Rabbits Demonstrates High and Durable Levels in the Chorioretina
por: Muya, Leroy, et al.
Publicado: (2022) -
Suprachoroidally Delivered DNA Nanoparticles Transfect Retina and Retinal Pigment Epithelium/Choroid in Rabbits
por: Kansara, Viral S., et al.
Publicado: (2020) -
Suprachoroidal gene transfer with nonviral nanoparticles
por: Shen, Jikui, et al.
Publicado: (2020)